Embark Veterinary
PrivateLast Round
Series B
Jul 26, 2021
Est. Valuation
$700M
Total Funding Raised
$91.5M
Company Overview
Embark Veterinary operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series B round in July 2021.
Embark Veterinary is a biotechnology company that provides canine genetic testing services to help pet owners, breeders, and veterinarians understand dog health, ancestry, and genetic disease risks.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Embark Veterinary Comparables
Compare Embark Veterinary with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DNA My Dog | 78% | |
| Neogen Corporation | 76% | |
| Ancestry | 76% |
For institutional investors. Book with your work email.
Embark Veterinary Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 26, 2021 | ||||
| Series A | Apr 10, 2019 | ||||
| Seed | Jul 18, 2017 | ||||
| Seed | May 31, 2016 |
For institutional investors. Book with your work email.
Embark Veterinary Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Series B, Series A, Seed |
| S32 | Seed, Series A |
| SoftBank Investment Advisers | Series B |
| SV Angel | Seed, Series B |
| Founder Collective | Seed |
| Material | Series A |
| F-Prime Capital | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Launched 'Long Stay, No Longer' initiative using DNA testing for shelter pets.
- Jul 26, 2021
$75M round led by SoftBank Group.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 9, 2026
Embark launches Behavior Insights in Massachusetts on Sep 9th '26, an in-app upgrade for Breed ID and Breed + Health customers that translates a dog's DNA into 15 genetic behavior insights and pairs them with one year of personalized, guided training.
For institutional investors. Book with your work email.
Embark Veterinary Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Embark Veterinary's valuation, stock price, and market status.
Is Embark Veterinary a public or private company?
Embark Veterinary is a private company.
What is the current stock price of Embark Veterinary?
Embark Veterinary is a private company, so its shares have no public market price. Caplight tracks Embark Veterinary's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Embark Veterinary worth (valuation)?
Embark Veterinary's valuation is estimated at $700.0M based on funding round data.
Can I buy Embark Veterinary stock?
Embark Veterinary shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Embark Veterinary's last funding round?
Embark Veterinary's most recent funding round was Series B on July 26, 2021.
Who are the main investors in Embark Veterinary?
Key investors in Embark Veterinary include Slow Ventures, SoftBank Investment Advisers, Founder Collective, F-Prime Capital, SoftBank Group.
Will Embark Veterinary IPO soon?
No public IPO plans have been announced for Embark Veterinary.
How can I track Embark Veterinary secondary market activity?
Caplight tracks bids, offers, and trades in Embark Veterinary's shares on secondary markets.